Items tagged with Drug-resistant TB
Dr Lucica Ditiu at the 45th Union Conference in Barcelona (post)
27 October 2014 - Barcelona - Dr Lucica Ditiu, Executive Secretary, Stop TB Partnership spoke to National Press Foundation, at the 45th Union Conference, in Barcelona, on inadequate funding for TB and the challenge of multidrug-resistant TB.
Preliminary data show high success rate for dramatically shortened multidrug-resistant TB treatment option (post)
Thursday, 30 October, 2014, Barcelona, Spain – A nine-month treatment regiment for multidrug-resistant tuberculosis (MDR-TB) appears to be as effective as a 12-month regiment, according to data from two new studies being presented today at the 45th World Conference on Lung Health in Barcelona, Spain.
Cochrane review of RDT for diagnosis of drug-resistant TB (post)
Researchers from the Cochrane Infectious Diseases Group, hosted at LSTM, have conducted an independent review to examine the diagnostic accuracy of the GenoType® MTBDRsl assay for the detection of resistance to second-line anti-tuberculosis drugs.
Lilly shares insights from decade-long technology transfer experience (post)
New white paper documents Lilly's philanthropic effort to expand access to multidrug-resistant tuberculosis medicines
Alarming levels of drug-resistant tuberculosis in HIV-infected patients in metropolitan Mumbai, India (post)
Abstract
Risk of MDR-TB rises with ongoing treatment in 9 countries (post)
Risk of further resistance to TB drugs rose with ongoing treatment of multidrug-resistant (MDR) TB, according to results of a 9-country analysis. Risk of further resistance was about 75% to 80% lower in countries that met international Green Light Committee (GLC) criteria.
New R&D models needed to tackle drug-resistant TB (post)
Tuberculosis has killed more people than any other infectious disease in human history, yet before 2013 no new drugs to treat the illness had been developed for more than 40 years.
Former MDR-TB patient and TB advocate, Marina, meets with the European Parliament (post)
Between 18th and 19th November, TB Europe Coalition members, RESULTS UK and Global Health Advocates, had the exciting opportunity to welcome Marina to Brussels to brief decision-makers on the severity of the TB epidemic (TB) in the European Union (EU). Marina fought two years to defeat multidrug-resistant TB (MDR-TB) and is now a great advocate on the issue. By bringing the perspective of MDR-TB patients, Marina highlighted the urgent need for action at regional level to fight TB and ensure the rights of TB patients.
Treatment outcomes in HIV positive and negative people with drug resistant TB in Khayelitsha, Cape Town (post)
An analysis of treatment outcomes in HIV positive and negative people with drug resistant (DR) tuberculosis (TB) in Khayelitsha showed similar treatment success and long-term mortality in the presence of ART.
Page 10 of 117 · Total posts: 0
←First 9 10 11 Last→